Event JSON
{
"id": "aba4ccff975d5e334281e664adeb989d02f8a5708acebe40d895348004a8ed76",
"pubkey": "ac0231309b8abb0f6429d6a2e543de55b53f4d40f7ade1b7458ccfae59d0007c",
"created_at": 1726780263,
"kind": 1,
"tags": [
[
"t",
"options"
],
[
"imeta",
"url https://s3.masto.ai/media_attachments/files/113/166/269/291/031/852/original/63cb0686433b136c.jpg",
"m image/jpeg"
],
[
"proxy",
"https://masto.ai/@unusual_whales/113166271348934664",
"web"
],
[
"t",
"stocks"
],
[
"t",
"finance"
],
[
"t",
"news"
],
[
"t",
"economics"
],
[
"proxy",
"https://masto.ai/users/unusual_whales/statuses/113166271348934664",
"activitypub"
],
[
"L",
"pink.momostr"
],
[
"l",
"pink.momostr.activitypub:https://masto.ai/users/unusual_whales/statuses/113166271348934664",
"pink.momostr"
],
[
"-"
]
],
"content": "Wegovy by Novo Nordisk, $NVO, is the first GLP-1 med to receive a positive opinion for reduced symptoms in people with obesity-related heart failure.\n\nUnusual Whales has partnered with @Temaetfs to showcase the $HRTS ETF, the first GLP-1 ETF.\n\nSee more: https://t.co/9jXYVHxuRS\n\n #news #finance #economics #stocks #options\nhttps://s3.masto.ai/media_attachments/files/113/166/269/291/031/852/original/63cb0686433b136c.jpg\n",
"sig": "8d425682dd3a360a9cd2a7596edd91613c4abedab56bdc24ef93fe8ce8f1fa916deebdb626429d444dcdd405e38e553dd5908284e82e6ab95b761168b9062993"
}